R. M. Goldberg

UGT1A1*28 Genotype and Irinotecan-Induced Neutropenia: Dose Matters

Janelle M. Hoskins, R. M. Goldberg, Peng Qu et al. · JNCI Journal of the National Cancer Institute · 2007 · 467 citations · Full text

Medicine, Hematology, Pharmacology +17

Local recurrence after curative resection of colorectal adenocarcinoma.

Fabrizio Michelassi, Luca Vannucci, JAIME J. AYALA et al. · PubMed · 1990 · 112 citations

Medicine, Oncology, Surgery +16

Postoperative adjuvant chemoradiation for gastric or gastroesophageal junction (GEJ) adenocarcinoma using epirubicin, cisplatin, and infusional (CI) 5-FU (ECF) before and after CI 5-FU and radiotherapy (CRT) compared with bolus 5-FU/LV before and after CRT: Intergroup trial CALGB 80101.

Chana Fuchs, Jennifer Tepper, Donna Niedzwiecki et al. · Journal of Clinical Oncology · 2011 · 106 citations

Medicine, Oncology, Radiation Oncology +17

Phase I trial of dolastatin-10 (NSC 376128) in patients with advanced solid tumors.

Henry C. Pitot, Edwin McElroy, Joel M. Reid et al. · PubMed · 1999 · 101 citations

Medicine, Oncology, Pharmacology +13

CONCOMITANT HUMAN IMMUNODEFICIENCY VIRUS PROTEASE INHIBITOR THERAPY MARKEDLY REDUCES TACROLIMUS METABOLISM AND INCREASES BLOOD LEVELS

Aasim Sheikh, David C. Wolf, Edward Lebovics et al. · Transplantation · 1999 · 91 citations

Medicine, Pharmacokinetics, Pharmacology +17